Edition:
United States

People: Accelerate Diagnostics Inc (AXDX.O)

AXDX.O on Consolidated Issue listed on NASDAQ Capital Market

19.50USD
23 Oct 2017
Change (% chg)

-- (--)
Prev Close
$19.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
329,046
52-wk High
$30.45
52-wk Low
$18.35

Strobeck, Matthew 

Dr. Matthew W. Strobeck, Ph.D. is Independent Director of Accelerate Diagnostics Inc. since July 7, 2012. Dr. Strobeck is currently the Managing Partner of Birchview Capital. Dr. Strobeck was a Partner and Member of the Management Committee and Advisory Board of Westfield Capital Management from 2008 until 2011, having served as a member of the investment team, specializing in healthcare and life sciences, from May 2003 to June 2008. Dr. Strobeck received his B.S. from St. Lawrence University, a Ph.D. from the University of Cincinnati, a S.M. from the Harvard University/MIT Health Sciences Technology Program, and a S.M. from the MIT Sloan School of Management.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 79,519
Fiscal Year Total, USD 79,519

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --